Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shigeru Igaki"'
Autor:
Shigeru Igaki, Ryosuke Hibino, Ken Tsuchida, Shinji Iwasaki, Satoru Matsuda, Ryujiro Hara, Hiroko Kamada, Masashi Toyofuku, Haruhide Kimura, Misa Iwatani, Rina Baba, Mitsuhiro Ito, Kota Matsumiya, Hideyuki Oki, Yusuke Kamada, Takeshi Hirakawa, Shinji Morimoto
Publikováno v:
Neuropsychopharmacology
Dysregulation of histone H3 lysine 4 (H3K4) methylation has been implicated in the pathogenesis of several neurodevelopmental disorders. Targeting lysine-specific demethylase 1 (LSD1), an H3K4 demethylase, is therefore a promising approach to treat t
Autor:
Ryuji Yamada, Mitsuhiro Ito, Hideyuki Oki, Yasushi Hattori, Yuuichi Arakawa, Matsumoto Shigemitsu, Satoru Matsuda, Atsushi Nakatani, Masaki Daini, Shigeru Igaki, Noriko Suzuki, Haruhide Kimura, Tatsuya Ando, Rina Baba
Publikováno v:
Science Advances
LSD1 inhibitor TAK-418 could be a therapeutic option for neurodevelopmental disorders via normalization of gene expression.
Persistent epigenetic dysregulation may underlie the pathophysiology of neurodevelopmental disorders, such as autism spec
Persistent epigenetic dysregulation may underlie the pathophysiology of neurodevelopmental disorders, such as autism spec
Autor:
Tatsuki, Asai, Naruhiko, Adachi, Toshio, Moriya, Hideyuki, Oki, Takamitsu, Maru, Masato, Kawasaki, Kano, Suzuki, Sisi, Chen, Ryohei, Ishii, Kazuko, Yonemori, Shigeru, Igaki, Satoshi, Yasuda, Satoshi, Ogasawara, Toshiya, Senda, Takeshi, Murata
Publikováno v:
Structure (London, England : 1993). 29(3)
The hERG channel is a voltage-gated potassium channel involved in cardiac repolarization. Off-target hERG inhibition by drugs has become a critical issue in the pharmaceutical industry. The three-dimensional structure of the hERG channel was recently
Autor:
Toshio Moriya, Shigeru Igaki, Satoshi Ogasawara, Satoshi Yasuda, Tatsuki Asai, Hideyuki Oki, Sisi Chen, Ryohei Ishii, Kazuko Yonemori, Takeshi Murata, Toshiya Senda, Naruhiko Adachi, Masato Kawasaki, Takamitsu Maru, Kano Suzuki
Publikováno v:
Structure. 29:203-212.e4
The hERG channel is a voltage-gated potassium channel involved in cardiac repolarization. Off-target hERG inhibition by drugs has become a critical issue in the pharmaceutical industry. The three-dimensional structure of the hERG channel was recently
Autor:
Satoshi Sogabe, Tomoya Sameshima, Kotaro Sakamoto, Takeshi Yamamoto, Junichi Sakamoto, Gotou Mika, Osamu Sano, Koh Ida, Ikuo Miyahisa, Yasuhiro Imaeda, Shigeru Igaki
Publikováno v:
Biochemistry. 57(8)
B-cell lymphoma 6 (BCL6) is the most frequently involved oncogene in diffuse large B-cell lymphomas (DLBCLs). BCL6 shows potent transcriptional repressor activity through interactions with its corepressors, such as BCL6 corepressor (BCOR). The inhibi
Autor:
Yoshihiro Kiyota, Craig A. Behnke, Takahiro Matsumoto, Junichi Miyazaki, Shigeru Igaki, Toru Kawamura, Mitsunori Kono, Masakuni Kori, Hideyuki Oki, Atsushi Nishimura, Masato Shimojo
Publikováno v:
Bioorganic & Medicinal Chemistry. 21:28-41
A series of piperazine ureas was designed, synthesized, and evaluated for their potential as novel orally available fatty acid amide hydrolase (FAAH) inhibitors that are therapeutically effective against pain. We carried out an optimization study of
Autor:
Tomoyasu Ishikawa, Youichi Kawakita, Douglas R. Cary, Takagi Shinji, Hiroshi Miki, Yoshikazu Ohta, Satoshi Sogabe, Terufumi Takagi, Hidehisa Iwata, Shigeru Igaki
Publikováno v:
ACS Medicinal Chemistry Letters. 4:201-205
The epidermal growth factor receptor (EGFR) family plays a critical role in vital cellular processes and in various cancers. Known EGFR inhibitors exhibit distinct antitumor responses against the various EGFR mutants associated with nonsmall-cell lun
Autor:
Yasuhiro Imaeda, Yuta Tanaka, Tomohiro Kawamoto, Ikuo Miyahisa, Katsuji Aikawa, Michiko Tawada, Nobuo Cho, Tomoyasu Ishikawa, Satoshi Sogabe, Tomoya Sameshima, Yumi Imai, Yumi Hayano, Goushi Nishida, Masakazu Inazuka, Misaki Homma, Shigeru Igaki
Publikováno v:
Journal of medicinal chemistry. 56(23)
Mcl-1 and Bcl-xL are crucial regulators of apoptosis, therefore dual inhibitors of both proteins could serve as promising new anticancer drugs. To design Mcl-1/Bcl-xL dual inhibitors, we performed structure-guided analyses of the corresponding select
Autor:
Tomoya Sameshima, Takeshi Yamamoto, Osamu Sano, Satoshi Sogabe, Shigeru Igaki, Kotaro Sakamoto, Koh Ida, Mika Gotou, Yasuhiro Imaeda, Junichi Sakamoto, Ikuo Miyahisa
Publikováno v:
Biochemistry; 2/27/2018, Vol. 57 Issue 8, p1369-1379, 11p
Autor:
Baba, Rina1, Satoru Matsuda1, Yuuichi Arakawa1, Ryuji Yamada1, Noriko Suzuki1, Tatsuya Ando2, Hideyuki Oki3, Shigeru Igaki3, Masaki Daini1, Yasushi Hattori1, Shigemitsu Matsumoto1, Mitsuhiro Ito1, Atsushi Nakatani1, Haruhide Kimura1 haruhide.kimura@takeda.com
Publikováno v:
Science Advances. 3/10/2021, Vol. 7 Issue 11, p1-15. 16p.